Associated Papers
Local delivery of hrBMP4 as an anticancer therapy in patients with recurrent glioblastoma: a first-in-human phase 1 dose escalation trial.
Bos EM et al.
Molecular Cancer, 2023
37563568 (PubMed )
Supplement: 12943_2023_1835_MOESM2_ESM.pdf
Select a paper to view details